Daily Bulletin

The Times Real Estate

.

European Commission Approves mAbxience's Bevacizumab For The Treatment Of Certain Types Of Cancer

  • Written by PR Newswire Asia - Daily Bulletin Au RSS

mAbxience, a global fully-fledged biotech company, with over a decade of experience in the development, manufacture and commercialization of biopharmaceuticals, is expanding patient access to biological treatments throughout Europe.

MADRID, March 31, 2021 /PRNewswire/ -- On 31 March 2021, the European Commission (EC) has approved...

Read more: European Commission Approves mAbxience's Bevacizumab For The Treatment Of Certain Types Of Cancer

Business News

pay.com.au unlocks untapped value through Avios and British Airways partnership

British Airways joins a growing list of transfer partners including Cathay Pacific and Thai Airways, empowering SMEs with expanded redemption options and flexibility  AUSTRALIA, 29 April 2025 — p...

Daily Bulletin - avatar Daily Bulletin

Why Ignoring a Windshield Chip Could Cost You More in the Long Run

(Source) When a stone from the road jumps to your windshield, you hear the distinctive tap. You check the glass window through your reflection to discover one tiny chip that seems insignificant. A sm...

Daily Bulletin - avatar Daily Bulletin

Top Tips for Landing Your First Job in Law

Starting your legal career is an exciting milestone – one that comes with its fair share of challenges and opportunities. Whether you’re fresh out of law school or looking to secure your first offic...

Daily Bulletin - avatar Daily Bulletin

LayBy Deals